Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this ...

Researchers identify bone-forming cells as the driver of scoliosis caused by a genetic disorder, which can be prevented ...

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield. Cancer that starts in the bones, ...

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...

Timely antiresorptive therapy post-osteoanabolic treatment is recommended, with less than one third of patients receiving it within 3 months.

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a few years ago that its use became mainstream. Originally crafted to help ...

Researchers have discovered a biological switch that explains why movement keeps bones strong. The protein senses physical ...

Dec. 11 -- THURSDAY, Dec. 10 (HealthDay News) -- Bone-building drugs used by tens of millions of women to fight osteoporosis also cut the risk of breast cancer, suggesting the drugs may play a dual ...

The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...

Two drugs used to treat osteoporosis may be better than either alone in maintaining bone density. Dr. Benjamin Leder and his colleagues at Massachusetts General Hospital found that combining ...